MyFinsight
Home
Blog
About
Back
Income Statement
Skye Bioscience, Inc. (SKYE)
Skye Bioscience, Inc. (SKYE)
source: myfinsight.com
Net loss
-$10,786,594
(38.80%↑ Y/Y)
Gains from asset sales
$178,200
(99.41%↑ Y/Y)
Interest and other
income, net
$103,208
(-80.64%↓ Y/Y)
Loss before income
taxes
-$10,783,194
(38.81%↑ Y/Y)
Provision for income taxes
$3,400
(0.00%↑ Y/Y)
Total other (income)
expense, net
$278,109
(-55.32%↓ Y/Y)
Interest expense
$3,299
Operating loss
-$11,061,303
(39.37%↑ Y/Y)
Total operating
expenses
$11,061,303
(-39.37%↓ Y/Y)
Research and development
$3,941,932
(-72.51%↓ Y/Y)
General and
administrative
$3,869,371
(-0.94%↓ Y/Y)
Change in estimate for
legal contingency
$3,250,000
Back